Shortage of Contrast for Imaging Services

Because of a global shortage of iodinated contrast material (Omnipaque) caused by temporary overseas manufacturing disruptions, ChristianaCare is taking steps to preserve supply so that it remains available for the most time-sensitive and urgent patient needs. (Learn more in our frequently asked questions.)

Omnipaque contrast is the most widely used contrast material for CT scans and radiographic examinations at ChristianaCare facilities. It is also used for cardiac imaging and interventions, and in the GI lab, Surgicenter and other settings.

The shortage is expected to last several weeks, and likely into the summer months.

Hospitals and health care organizations worldwide are managing the effects of the shortage and the impact to patient care.

ChristianaCare is making every effort to meet the needs of patients who need this product in their procedures. We are working individually with physicians to prioritize those patients with the most urgent needs.

Wherever possible, we are using alternative contrast material and limiting its use to ensure adequate supplies for time sensitive and emergent exams. It is possible that some elective procedures that use this product will need to be delayed.

ChristianaCare will continue to look for options to minimize disruptions created by the shortage, as we serve our community as expert, caring partners in health.

Learn more in our frequently asked questions (FAQs).

COVID-19: New Visitation Guidelines. Click here for what to expect at ChristianaCare during COVID-19.

ChristianaCare

Shortage of Contrast for Imaging Services

Because of a global shortage of iodinated contrast material (Omnipaque) caused by temporary overseas manufacturing disruptions, ChristianaCare is taking steps to preserve supply so that it remains available for the most time-sensitive and urgent patient needs. (Learn more in our frequently asked questions.)

Omnipaque contrast is the most widely used contrast material for CT scans and radiographic examinations at ChristianaCare facilities. It is also used for cardiac imaging and interventions, and in the GI lab, Surgicenter and other settings.

The shortage is expected to last several weeks, and likely into the summer months.

Hospitals and health care organizations worldwide are managing the effects of the shortage and the impact to patient care.

ChristianaCare is making every effort to meet the needs of patients who need this product in their procedures. We are working individually with physicians to prioritize those patients with the most urgent needs.

Wherever possible, we are using alternative contrast material and limiting its use to ensure adequate supplies for time sensitive and emergent exams. It is possible that some elective procedures that use this product will need to be delayed.

ChristianaCare will continue to look for options to minimize disruptions created by the shortage, as we serve our community as expert, caring partners in health.

Learn more in our frequently asked questions (FAQs).

COVID-19: New Visitation Guidelines. Click here for what to expect at ChristianaCare during COVID-19.

Physicians & Staff

Janice E. Nevin, M.D., MPH

President and Chief Executive Officer

A visionary and collaborative health care leader, Janice E. Nevin, M.D., MPH, has served as president and CEO of ChristianaCare since 2014, leading a transformation from a health care system to a system that truly impacts health. She is nationally recognized as a pioneer and thought leader in value-based care and population health, and for her assertion that truly great health care is built on the values of love and excellence. These values are exemplified in her commitment to health equity and anti-racism, and to improving health, making high-quality care more accessible and lowering health care costs for everyone in the communities that ChristianaCare has the privilege to serve. Her leadership has also vaulted ChristianaCare to national recognition for its advancement of caregiver wellbeing through the work of the Center for WorkLife Wellbeing.

Under Dr. Nevin’s leadership, ChristianaCare developed the unique data-driven care coordination platform CareVio™ to proactively address patients’ social and behavioral health needs in addition to their medical needs. This program supports patients across the continuum of care and is demonstrating better health outcomes while reducing the cost of care. It earned the 2017 John M. Eisenberg Patient Safety and Quality Award, the nation’s preeminent recognition for quality and safety in health care, and a 2017 Stand Up for Patient Safety Management Award from the National Patient Safety Foundation.

Dr. Nevin also led the development of eBrightHealth ACO, an accountable care organization to improve care coordination, clinical quality and value in Delaware and the region.

Modern Healthcare selected Dr. Nevin as one of its 50 Most Influential Clinical Executives in both 2020 and 2021 in addition to naming her to the publication’s Top 25 Women Leaders in 2019 and 2022. The Philadelphia Business Journal included her in its 2022 Power 100, a list of the region’s most influential leaders. Dr. Nevin has been inducted into the Delaware Women’s Hall of Fame and was recognized among 100 Great Healthcare Leaders to Know in 2018 by Becker’s Hospital Review.

For her commitment to the community, she received the 2020 Citizen of the Year Award with the Del-Mar-Va Council Boy Scouts of America; the Humanitarian Award from the Limen House in 2018; and Delaware’s Grassroots Champion Award from the American Hospital Association and the David G. Menser Award from the Wilmington Senior Center, both in 2017.

Dr. Nevin serves on the board of trustees of the American Hospital Association (AHA) and is a member of the AHA Committee on Health Strategy & Innovation. She is secretary of the board of directors of America’s Essential Hospitals and a member of the organization’s executive committee. Dr. Nevin also sits on the boards for Cross Country Healthcare and the Delaware State Chamber of Commerce. She chairs the Delaware Business Roundtable Executive Committee and is a member of the United States of Care Founder’s Council, the CEO Council for Growth of the Chamber of Commerce for Greater Philadelphia.

Dr. Nevin graduated from Harvard University and earned her medical degree with honors from Sidney Kimmel Medical College at Thomas Jefferson University. She completed her family medicine residency at Thomas Jefferson University Hospital and her Master of Public Health degree at the University of Pittsburgh. She joined ChristianaCare in 2002, as Chair of the Department of Family and Community Medicine. Dr. Nevin is a Professor of Family and Community Medicine at Sidney Kimmel Medical College at Thomas Jefferson University.

Specialties: Family Medicine
Contact:

Office of the President & CEO
501 West 14th Street
Wilmington, DE 19801

Education: Thomas Jefferson Medical College
University Of Pittsburgh
Residency: Thomas Jefferson Medical Center
Fellowship: University of Durham
University of Pittsburgh Medical Center